Please select the option that best describes you:

What is your approach to vaccinations and titers for patients with myeloma, who are immunosuppressed and do not have appropriate antibody responses to vaccines?  

E.g., for a patient with myeloma, s/p induction therapy, and high-dose chemotherapy, followed by autologous rescue with inappropriate antibody response to TDAP?



Answer from: at Academic Institution

Answer from: at Academic Institution

Answer from: at Academic Institution